Bone Neoplasms News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Effective treatment of low-dose decitabine in myelodysplastic syndrome/myeloproliferative neoplasms - Dove Medical Press



Effective treatment of low-dose decitabine in myelodysplastic syndrome/myeloproliferative neoplasms 
Dove Medical Press
Materials and methods: A female patient was diagnosed with MDS/MPN through bone marrow cytology, immunology, cell genetics, molecular biology, and pathology. She received thalidomide and prednisone as initial treatment. Ten months later, the first-line ...

 


Global Bone Marrow Transplant Market to 2025 by Transplant Type, Disease Indication, End-User & Geography - PR Newswire (press release)



Global Bone Marrow Transplant Market to 2025 by Transplant Type, Disease Indication, End-User & Geography 
PR Newswire (press release)
By disease indication, the market is segmented by aplastic anemia, thalassemia, sickle cell anemia, leukemia, lymphoma, myelodysplasia, myeloma, myeloproliferative neoplasms, solid tumors, and other disease indication. Depending on the end user the ...

and more » 


Myeloproliferative Neoplasms Treatment Market By Drug (Jakfi) ? Global Industry Insights, Trends, Outlook, And ... - Medgadget (blog)



Myeloproliferative Neoplasms Treatment Market By Drug (Jakfi) ? Global Industry Insights, Trends, Outlook, And ... 
Medgadget (blog)
Myeloproliferative Neoplasms (MPNs) are a group of rare disease, in which the bone marrow produces excess blood cells. It can be white blood cells, red blood cells or platelets. The overproduction of blood cells by the bone marrow creates hindrance in ...

 


Epiomic Epidemiology Series: Myeloproliferative Neoplasms Forecast In 12 Major Markets 2017-2027 - PR Newswire (press release)



Epiomic Epidemiology Series: Myeloproliferative Neoplasms Forecast In 12 Major Markets 2017-2027 
PR Newswire (press release)
Myeloproliferative neoplasms (MPNs) are a group of diseases that concern the clonal proliferation of precursors of the myeloid lineage cells in the bone marrow. MPNs are characterized by uncontrolled cell growth, and therefore can also be classified as ...

 


Myeloproliferative Neoplasms Forecast in 12 Major Markets 2017-2027 - USA, Canada, France, Germany, Italy, Spain ... - Business Wire (press release)



Myeloproliferative Neoplasms Forecast in 12 Major Markets 2017-2027 - USA, Canada, France, Germany, Italy, Spain ... 
Business Wire (press release)
Myeloproliferative neoplasms (MPNs) are a group of diseases that concern the clonal proliferation of precursors of the myeloid lineage cells in the bone marrow. MPNs are characterized by uncontrolled cell growth, and therefore can also be classified as ...

and more » 


Minimal residual disease shows significant prognostic value for multiple myeloma - Healio



Minimal residual disease shows significant prognostic value for multiple myeloma 
Healio
?Previous studies in different lymphoid neoplasms have reported a sensitivity difference between the various techniques, with next-generation sequencing-based methods demonstrating greater sensitivity compared [with] flow cytometry and allele-specific ...

 


In The Spotlight: Stemline Therapeutics - Nasdaq



KL Daily
 
In The Spotlight: Stemline Therapeutics 
Nasdaq
SL-401 is under a phase II potentially pivotal trial in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). BPDCN is a rare and aggressive hematologic malignancy of the bone marrow and blood that can affect other organs such as the ...
Stemline Therapeutics, Inc. - STML - Stock Price Today - Zacks Zacks Investment Research

all 22 news articles » 


Radical Prostatectomy for Patients With Oligometastatic Prostate Cancer - Cancer Network



Radical Prostatectomy for Patients With Oligometastatic Prostate Cancer 
Cancer Network
[30,55] Furthermore, by producing the necessary chemokines, angiogenic factors, fibronectin, bone marrow infiltrate cells, and other hormonal factors, the primary tumor appears to play a role in the development and maintenance of metastases.[56,57 ...

 


Acute leukemia ? driving toward precision and targeted medicine - Open Access Government



Open Access Government
 
Acute leukemia ? driving toward precision and targeted medicine 
Open Access Government
Acute leukaemia results in bone marrow failure, and comprise the two major haematological disease groups, acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML). Normal bone marrow ... The adoption of WHO classification of hematopoietic ...

 


Incyte Starts Clinical Trial Of Ruxolitinib For Essential Thrombocythemia - Markets Insider



Incyte Starts Clinical Trial Of Ruxolitinib For Essential Thrombocythemia 
Markets Insider
... as myeloproliferative neoplasms or MPNs, characterized by increased platelet production, a white cell count above the normal range, persistently elevated platelet counts with normal red blood cell mass and the absence of prominent bone marrow fibrosis.

and more »